Unraveling elements of value-based pricing from a pharmaceutical industry's perspective: a scoping review

Health authorities use value-based pricing models to determine the value of innovative drugs and to establish a price. Pharmaceutical companies prefer value-based pricing over cost-based pricing. It is ambiguous whether value-based pricing has the same meaning to these stakeholders. We aimed to iden...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aniek Dane (Autor), Carin Uyl-de Groot (Autor), Hugo van der Kuy (Autor)
Formato: Libro
Publicado: Frontiers Media S.A., 2024-06-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible